Teva Pharmaceutical (TEVA.US) Surges Over 15% in Pre-Market Trading on Proposed $4.35 Billion Opioid Settlement with U.S. States and Tribes

Gelonghui July 27th丨Teva Pharmaceutical (TEVA.US) pre-market rose 15.03%, trading at $8.19. In terms of news, Teva Pharmaceutical has reached a preliminary agreement with U.S. states and Native American tribes regarding claims related to addiction responses in the U.S. opioid crisis. Under the proposed settlement agreement, states will receive $4.25 billion, while tribes will receive $100 million, to be paid over 13 years.